Trilegal Advised Aurobindo Pharma Group On The Acquisition Of The Branded Non-Oncology Prescription Formulations Business Of KLabs

Trilegal advises Aurobindo Pharma Group on acquiring KLabs’ branded non-oncology prescription formulations.

Update: 2026-01-02 12:45 GMT


Trilegal advised Aurobindo Pharma Group on the acquisition of the branded non-oncology prescription formulations business of KLabs

The leading law firm in India, Trilegal advised Auro Pharma Limited, a wholly owned subsidiary of Aurobindo Pharma Limited, on its acquisition of the branded non-oncology prescription formulation business of Khandelwal Laboratories Private Limited on a slump sale basis.

The acquisition strengthens Aurobindo Pharma Group’s domestic branded formulations platform by adding established brands in the pain management and anti-infective segments, complementing its existing product portfolio and supporting further expansion in the Indian pharmaceutical market.

Trilegal provided end-to-end legal support on the transaction, including conducting legal due diligence, drafting and negotiating the transaction documents, and assisting with closing.

The Trilegal Transaction Team advising on the matter was led by Siddharth Dang (Partner) and supported by Rutvi Shrimankar (Senior Associate), and Sanchit Thapliyal, Rohan Singhal, and Shubh Jaiswal (Associates).

The Trilegal Intellectual Property Team advising on the matter was led by Kirti Balasubramanian (Partner) and Hitarth Parikh (Associate).

The Trilegal Employment Team advising on the matter was led by Parvathy Tharamel (Partner) and supported by Koshy Mathen and Gokul Suresh Nair (Associates).

The Trilegal Due Diligence Team advising on the matter was led by Siddharth Dang, Ankit Kejriwal, Kirti Balasubramanian, and Parvathy Tharamel (Partners), and supported by Rutvi Shrimankar and Rutvij Naik (Senior Associates), and Sanchit Thapliyal, Shubh Jaiswal, Hitarth Parikh, Dhanush T, Koshy Mathen, and Gokul Suresh Nair (Associates).

Click to know more about Trilegal

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.


Tags:    

Similar News